Biostatistics Flashcards
Collects data from a group of people to assess frequency of disease (and related risk factors) at a particular point in time
-asks “What is happening?”
Cross-sectional study
A cross-sectional study can show risk factor association with disease, but does not establish
Causality
Compares a group of people with a disease to a group of people without a disease
- Looks for prior exposure or risk factor
- Asks “What happened?”
Case-control study
Case-control studies measure
Odds ratio
Compares a group with a given exposure or risk factor to a group without such exposure.
-Looks to see if exposure affects the likelihood of disease
Cohort study
Asks “Who will develop the disease?
Prospective cohort
Asks “Who developed the disease? the exposed or unexposed?”
Retrospective cohort
What type of study would say “Patients with COPD had higher odds of a history of smoking than those without COPD?”
Case-control Study
What type of study would say “Smokers had a higher risk of developing COPD than nonsmokers?”
Cohort Study
Compares the frequency with which both monozygotic or both dizygotic twins develop the same disease
-Measures heritability and influence of environmental factors
Twin concordance study
Compares siblings raised by biological vs. adoptive parents
-measures heritability and influence of environmental factors
Adoption study
Experimental study involving humans. Compares therapeutic benefits of two or more treatments or of treatment and placebo
-Study quality improves with double blinding and randomization
Clinical Trial
Refers to the additional blinding of the researchers analyzing the data
Triple-blinding
Requires a small number of healthy volunteers and asseses safety, toxicity, pharmokinetics, and pharmodynamics
Phase I trial
Requires a small number of patients with the disease of interest and assesses treatment efficacy, optimal dosing, and adverse effects
Phase II trial
Requires a large number of patients randomly assigned either to the treatment under investigation or to the best available treatment (or placebo)
-compares new treatment to current standard of care
Phase III trial
Requires post marketing surveillance of pateints after treatment is approved
- detects rare or long-term adverse effects
- can result in treatment being withdrawn from market
Phase IV trials
Sensitivity and specificity are fixed properties of a test, where as PPV and NPV vary depending on
Disease prevalence
Proportion of all people with the disease who test positive, or the probability that when the disease is present, the test is positive
Sensitivity
Highly sensitive tests are used for screening in diseases with
Low prevalence
Desirable for ruling out disease and indicates a low false-negative rate
Highly sensitive test
Proportion of all people without the disease who will test negative for the disease
Specificity
Desirable for ruling in a disease and indicates a low false-positive rate
Highly specific test
How an we remember what sensitive and specific tests are used for?
- ) Sensitive: SN-N-OUT
2. ) Specific: SP-P-IN
Used for conformation after a positive screening
Highly specific test
Proportion of positive test results that are true positives
Positive predictive value (PPV)
Proportion of negative results that are true negatives
Negative predictive value (NPV)
High prevalence means what for PPV and NPV?
High prevalence = High PPV and Low NPV
Looks at new cases
Incidence
Looks at all current cases
Prevalence
What is the incidence rate?
new cases / # people at risk
What is the prevalence?
of existing cases / Total # of people
Prevalence is greater than incidence for
Chronic diseases